07.09.2010 • News

Umicore Obtains License From Japan Science and Technology Agency

Umicore has signed a license agreement with Japan Science and Technology Agency expanding its technology offering to the nobel-prize winning asymmetric ketone hydrogenation technologies of professors Noyori and Ikariya. Under the license, Umicore is allowed to market Ruthenium diammine and diphosphine Ruthenium diammine catalysts on an industrial scale.

"With this technology expansion we are able to give our customers access to JST's extremely powerful technology," says Dr. Matthias Grehl, vice president BU precious metals chemistry. "Our customers can use these catalysts in their vessels to transfer ketones into chiral alcohols. This license complements our current intellectual property for chiral ligands and catalysts for example those of the MeOBIPHEP or Josiphos type."

The agreement underlines the strategic focus of Umicore precious metals chemistry on emerging applications for organometallic precious metals  chemistry in general and in homogeneous catalyst technologies in particular. Besides chiral catalysts, Umicore precious metals chemistry develops  catalysts for metathesis applications and for C-X coupling reactions, and provides innovative solutions for precious metals separation and recovery for homogeneous catalysis processes.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.